Skip to main navigation
Skip to search
Skip to main content
Sort by
Biochemistry, Genetics and Molecular Biology
ARG1
34%
Bisulfite Sequencing
8%
CD160
17%
CD244
8%
CD33
21%
CD4
43%
CD8
18%
Chromatin Immunoprecipitation
8%
CTLA-4
8%
Disease Specific Survival
34%
DNA Hypomethylation
13%
Downregulation
9%
Epigenetic Modification
8%
Epigenetics
34%
Galectin
34%
Gene Signature
34%
Genetic Risk
34%
Genetic Screening
17%
Genome-Wide Association Study
7%
Histone H3
26%
HLA-DR
34%
HLA-DRA
34%
Immune Checkpoints
34%
Immunosurveillance
6%
Impaired Glucose Tolerance
34%
Insulin Resistance
34%
Lysine
26%
Messenger RNA
17%
PD-L1
26%
Polygenic Score
34%
PRDM1
8%
Prevalence
69%
Promoter Region
17%
Quantitative Reverse Transcription Polymerase Chain Reaction
8%
Real-Time Polymerase Chain Reaction
8%
Sex Differences
34%
Subtyping
34%
T Cell
69%
TIGIT
26%
Transcriptome
34%
Tumor-Infiltrating Lymphocytes
33%
Upregulation
26%
Volume
13%
Keyphrases
Actual Age
11%
Area under the Curve
7%
Arginase-1 (Arg-1)
34%
Biobank
69%
Breast Cancer Cells
9%
Cancer Immunotherapy
34%
CD160
9%
Chronic Kidney Disease
17%
Diabetes Subtypes
11%
Differentially Expressed Pathways
8%
DNA Hypomethylation
11%
Evaluation Index
34%
Exhaustion Marker
34%
Genetic Risk
34%
Genome-wide Association Study
7%
High Risk
11%
Histone H3 Lysine 4
17%
HLA-A*0201
34%
Hypoxia-related Genes
8%
Immune Cell Recruitment
8%
Immunogenic Epitopes
34%
Insulin
8%
Insulin Resistance
34%
Lactate Dehydrogenase C
34%
Maturity-onset Diabetes of the Young
17%
Metabolic-associated Fatty Liver Disease (MAFLD)
17%
Middle Eastern
34%
Mild Age-related Diabetes
28%
Mild Obesity-related Diabetes
17%
Myeloid Lineage
8%
Peptide Pools
9%
Polygenic Risk Score
34%
Pre-diabetes (pre-DM)
34%
Precision Medicine
34%
Pro-tumor
8%
Prognosis Score
13%
Qatar Biobank
16%
Real-time Reverse Transcriptase PCR
8%
Risk Index
34%
Severe Insulin-deficient Diabetes
17%
Severe Insulin-resistant Diabetes
17%
Suppressive Molecules
11%
T Cell Activation
9%
T Cells
12%
TIGIT
14%
TOX2
26%
Tumor-associated Myeloid Cells
17%
Tumor-infiltrating T Cells
34%
Type 2 Diabetes Mellitus (T2DM)
72%
Young Individuals
11%
Immunology and Microbiology
Angiogenesis
6%
Cancer Cell
17%
Cancer Immunotherapy
34%
Cancer Testis Antigen
8%
CD33
34%
CD4
43%
CD8
22%
Cell Population
6%
Chromatin Immunoprecipitation
8%
CTLA-4
8%
Cytotoxic T Cell
6%
Disease Specific Survival
40%
Downregulation
13%
Ecalectin
34%
Epigenetic Modification
8%
Epigenetics
34%
Epitope
34%
Gene Expression
34%
Immunocompetent Cell
12%
Immunotherapy
8%
In Vitro
8%
Inflammation Response
12%
Insulin
44%
Insulin Resistance
34%
Lineages
5%
Mortality Rate
5%
Myeloid
34%
Peptides
37%
Prevalence
43%
Programmed Death-Ligand 1
26%
Promoter Region
17%
Quantitative Reverse Transcription Polymerase Chain Reaction
8%
Real-Time Polymerase Chain Reaction
8%
Regulatory T Cell
6%
Secretion (Process)
8%
Sex Differences
8%
T Cell
100%
T Cell Activation
15%
T-Helper Cell
34%
Transcriptome
34%
Transcriptomics
12%
Tumor-Infiltrating Lymphocytes
43%
Upregulation
26%
Volume
21%